KHAITAN CHEMICALS & FERTILIZERS
|
|
BOM : 507794     NSE : KHAICHEM     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward Pledged Shares : None or < 25% |
Jul 11,2025 |
Price(EOD): ₹ 96.92
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Fertilizers |
MCap: ₹ 940.12 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
KHAITAN CHEMICALS & FERTILIZERS | -2.2% | 14.3% | 17.5% |
COROMANDEL INTERNATIONAL | 2.6% | 0.7% | 42.6% |
THE FERTILISERS AND CHEMICALS TRAVANCORE | -1.4% | -11.2% | -16.2% |
CHAMBAL FERTILISERS AND CHEMICALS | -4% | -1.7% | 7.4% |
DEEPAK FERTILISERS AND PETROCHEMICALS CORPORATION | -1.9% | 1% | 102.4% |
GUJARAT NARMADA VALLEY FERTILIZERS & CHEMICALS | -2.4% | -0.5% | -22.6% |
PARADEEP PHOSPHATES | 3.7% | -4.9% | 80.5% |
GUJARAT STATE FERTILIZERS & CHEMICALS | -2.3% | -2.5% | -20.6% |
RASHTRIYA CHEMICALS AND FERTILIZERS | -1.6% | -4.7% | -33.4% |
FUNDAMENTAL ANALYSIS OF KHAITAN CHEMICALS & FERTILIZERS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF KHAITAN CHEMICALS & FERTILIZERS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
671.44
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 1.40 Cr
[Latest Qtr - Mar2025 - Standalone Results ] 4.22
P/B Calculated based on Book Value of Rs 222.64 Cr
[Latest Year - Mar2025 - Standalone Results ] 1.31
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Mar2025 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 218% 227% |
SHARE PRICE MOMENTUM OF KHAITAN CHEMICALS & FERTILIZERS
KHAITAN CHEMICALS & FERTILIZERS vs SENSEX
DEBT OF KHAITAN CHEMICALS & FERTILIZERS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
1.4 0.75 0.54 0.9 |
- - - - |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF KHAITAN CHEMICALS & FERTILIZERS
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2025 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF KHAITAN CHEMICALS & FERTILIZERS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-19.16% -1.74% 8.02% -31.27% |
216.12% 138.42% 102.63% 123.06% |
QtrlyTrend |
2 | |
Latest Qtr: Mar2025 | ||
Quarterly Result Analysis → |
KHAITAN CHEMICALS & FERTILIZERS related INDICES
You may also like the below Video Courses
FAQ about KHAITAN CHEMICALS & FERTILIZERS
Is KHAITAN CHEMICALS & FERTILIZERS good for long term investment?
As on Jul 11,2025, the Fundamentals of KHAITAN CHEMICALS & FERTILIZERS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of KHAITAN CHEMICALS & FERTILIZERS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is KHAITAN CHEMICALS & FERTILIZERS UnderValued or OverValued?
As on Jul 11,2025, KHAITAN CHEMICALS & FERTILIZERS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of KHAITAN CHEMICALS & FERTILIZERS ?
As on Jul 11,2025, the Intrinsic Value of KHAITAN CHEMICALS & FERTILIZERS is Rs. 30.04 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -75.95
Fair Value [Median EV / Sales Model] : Rs. 30.45
Fair Value [Median Price / Sales Model] : Rs. 29.63
Estimated Median Fair Value of KHAITAN CHEMICALS & FERTILIZERS : Rs. 30.04
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.